Fernando Lecanda

4PUBLICATIONS
36CO-AUTHORS
Predictive and prognostic markersRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jan 31, 2023
ENPP1 Immunobiology as a Therapeutic Target.

Borja Ruiz-Fernández de Córdoba, Rafael Martínez-Monge, Fernando Lecanda

|Jan 06, 2023
LAMC2 Regulates Key Transcriptional and Targetable Effectors to Support Pancreatic Cancer Growth.

Oihane Erice, Shruthi Narayanan, Iker Feliu

|Feb 22, 2022
Tumor ENPP1 (CD203a)/Haptoglobin Axis Exploits Myeloid-Derived Suppressor Cells to Promote Post-Radiotherapy Local Recurrence in Breast Cancer.

Borja Ruiz-Fernández de Córdoba, Haritz Moreno, Karmele Valencia

|Feb 01, 2018
Radiation effects on antitumor immune responses: current perspectives and challenges.

Thomas Walle, Rafael Martinez Monge, Adelheid Cerwenka

Pageof 1